Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-24-000930
Filing Date
2024-10-15
Accepted
2024-10-15 11:58:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3869
  Complete submission text file 0001968582-24-000930.txt   5512
Mailing Address ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119
Business Address
GUYER DAVID R (Reporting) CIK: 0001277476 (see all company filings)

Type: 144

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-51122 | Film No.: 241370770
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)